Medco Energi Internasional MEDC IJ Buy- Earnings driven by AMMNs contribution
In our recent report, we mentioned that one of the main catalysts for MEDC is AMMN IJ (Not rated)s operational
Commodities and Energy SH SC 1.3K 14th Oct, 2025
Maintain Buy with higher TP of IDR2,300
Expecting stronger CPO price trend
We revise up our ASP forecasts for TAPG by +3.5%/+3.0% y-y for FY25F/26F on the back of a stronger CPO price trend, driven by additional demand from B45 in 1H26F and B50 in 2H26F. We reckon that the incremental demand from Indonesia biodiesel expansion could contribute >50% of total additional global demand annually. In our view, B50 is feasible for implementation next year, given ample CPO fund budget (see Fig. 4), sufficient biodiesel capacity (at 19.6mn kilolitres vs B50 demand for 19.2mn kilolitres), and full government support aimed at reducing oil imports (main agenda of energy security program). We project CPO price hike of +20%/+5% in FY25F/FY26F, with a price level structurally above that for soybean oil (see Fig. 2 and 6).
Highly profitable with generous dividend
We calculate that TAPG’s cash cost is the lowest among peers in the upstream business (see Fig. 7), driven by high production yield (~14-year age profile) and efficient operations, in our view. This also explains TAPG’s superior fresh fruit bunch (FFB) production growth of +15% y-y in 1H25 (vs +6% average for peers). Thus, we expect TAPG to record better earnings growth than the industry. Furthermore, the company maintained a generous dividend payout ratios of 112%/98% in FY23/24 – it may potentially offer a 9% dividend yield for the FY25F book. The company delivers one of the highest dividend payouts among plantation firms, which helps boost its ROE to 32% in FY25F (highest among peers; see Fig. 1); this also signals strong corporate governance practices, in our view. Going forward, management plans to use more organic fertilizers to reduce costs and emission, which could further drive margin expansion.
Maintain Buy with higher TP, incorporating higher ASP and potential fine payment
We upgrade earnings by 8%/2% for FY25F/FY26F, given higher ASP assumptions and incorporating a potential fine from the use of forestry land in the FY26F book. We note the potential fine to be a one-off cost and hence, not substantial in our forecast; we still forecast TAPG’s FY26F NPAT to grow by +10% y-y. We rate the stockBuy with a higher TP of IDR2,300 (from IDR2,100), using a target P/E of 13x FY25F (unchanged, similar to ASEAN peers). We believe that CPO players deserve valuation re-rating given their expanding profitability and better predictability than other commodities. Given potential upside of 24% and dividend yield of 9.3%, TAPG’s TSR is at 33.3%. Downside risks would be the cancellation of biodiesel mandate expansion and unfavorable government intervention.
| Year-end 31 Dec | FY24 | FY25F | FY26F | FY27F | |||
| Currency (IDR) | Actual | Old | New | Old | New | Old | New |
| Revenue (bn) | 9,671 | 10,695 | 11,010 | 11,660 | 11,940 | 11,822 | 12,106 |
| Reported net profit (bn) | 3,120 | 3,243 | 3,500 | 3,752 | 3,841 | 3,854 | 4,099 |
| Normalised net profit (bn) | 3,120 | 3,243 | 3,500 | 3,752 | 3,841 | 3,854 | 4,099 |
| FD normalised EPS | 157.19 | 163.38 | 176.33 | 189.00 | 193.52 | 194.17 | 206.50 |
| FD norm. EPS growth (%) | 94.0 | 3.9 | 12.2 | 15.7 | 9.8 | 2.7 | 6.7 |
| FD normalised P/E (x) | 11.8 | – | 10.5 | – | 9.6 | – | 9.0 |
| EV/EBITDA (x) | 8.5 | – | 7.3 | – | 6.4 | – | 6.2 |
| Price/book (x) | 3.4 | – | 3.3 | – | 3.2 | – | 3.1 |
| Dividend yield (%) | 8.3 | – | 9.3 | – | 10.2 | – | 10.9 |
| ROE (%) | 28.8 | 29.8 | 31.7 | 33.3 | 33.5 | 33.1 | 34.6 |
| Net debt/equity (%) | net cash | 0.7 | net cash | net cash | net cash | net cash | net cash |
Income statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY23 | FY24 | FY25F | FY26F | FY27F | ||||||||||||||
Revenue | 8,326 | 9,671 | 11,010 | 11,940 | 12,106 | ||||||||||||||
Cost of goods sold | -6,109 | -5,949 | -6,638 | -6,937 | -6,953 | ||||||||||||||
Gross profit | 2,217 | 3,723 | 4,373 | 5,003 | 5,153 | ||||||||||||||
SG&A | -875 | -894 | -998 | -1,031 | -1,050 | ||||||||||||||
Employee share expense | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Operating profit | 1,342 | 2,829 | 3,375 | 3,973 | 4,102 | ||||||||||||||
EBITDA | 1,954 | 3,445 | 4,106 | 4,778 | 4,990 | ||||||||||||||
Depreciation | -612 | -617 | -731 | -805 | -887 | ||||||||||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
EBIT | 1,342 | 2,829 | 3,375 | 3,973 | 4,102 | ||||||||||||||
Net interest expense | -75 | -11 | -4 | 39 | 40 | ||||||||||||||
Associates & JCEs | 643 | 894 | 1,034 | 1,062 | 1,069 | ||||||||||||||
Other income | 30 | 216 | 8 | -204 | 8 | ||||||||||||||
Earnings before tax | 1,941 | 3,927 | 4,412 | 4,870 | 5,220 | ||||||||||||||
Income tax | -280 | -686 | -743 | -838 | -913 | ||||||||||||||
Net profit after tax | 1,661 | 3,241 | 3,669 | 4,032 | 4,307 | ||||||||||||||
Minority interests | -53 | -120 | -169 | -190 | -208 | ||||||||||||||
Other items | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Preferred dividends | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Normalised NPAT | 1,608 | 3,120 | 3,500 | 3,841 | 4,099 | ||||||||||||||
Extraordinary items | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Reported NPAT | 1,608 | 3,120 | 3,500 | 3,841 | 4,099 | ||||||||||||||
Dividends | -1,807 | -3,057 | -3,430 | -3,764 | -4,016 | ||||||||||||||
Transfer to reserves | -198 | 63 | 71 | 78 | 83 | ||||||||||||||
Valuations and ratios | |||||||||||||||||||
Reported P/E (x) | 22.9 | 11.8 | 10.5 | 9.6 | 9.0 | ||||||||||||||
Normalised P/E (x) | 22.9 | 11.8 | 10.5 | 9.6 | 9.0 | ||||||||||||||
FD normalised P/E (x) | 22.9 | 11.8 | 10.5 | 9.6 | 9.0 | ||||||||||||||
Dividend yield (%) | 4.9 | 8.3 | 9.3 | 10.2 | 10.9 | ||||||||||||||
Price/cashflow (x) | 17.7 | 9.7 | 8.9 | 8.0 | 7.4 | ||||||||||||||
Price/book (x) | 3.4 | 3.4 | 3.3 | 3.2 | 3.1 | ||||||||||||||
EV/EBITDA (x) | 14.4 | 8.5 | 7.3 | 6.4 | 6.2 | ||||||||||||||
EV/EBIT (x) | 18.8 | 10.0 | 8.5 | 7.4 | 7.3 | ||||||||||||||
Gross margin (%) | 26.6 | 38.5 | 39.7 | 41.9 | 42.6 | ||||||||||||||
EBITDA margin (%) | 23.5 | 35.6 | 37.3 | 40.0 | 41.2 | ||||||||||||||
EBIT margin (%) | 16.1 | 29.2 | 30.7 | 33.3 | 33.9 | ||||||||||||||
Net margin (%) | 19.3 | 32.3 | 31.8 | 32.2 | 33.9 | ||||||||||||||
Effective tax rate (%) | 14.4 | 17.5 | 16.8 | 17.2 | 17.5 | ||||||||||||||
Dividend payout (%) | 112.3 | 98.0 | 98.0 | 98.0 | 98.0 | ||||||||||||||
ROE (%) | 15.4 | 28.8 | 31.7 | 33.5 | 34.6 | ||||||||||||||
ROA (pretax %) | 15.6 | 28.8 | 33.1 | 36.2 | 35.8 | ||||||||||||||
Growth (%) | |||||||||||||||||||
Revenue | -10.9 | 16.2 | 13.8 | 8.4 | 1.4 | ||||||||||||||
EBITDA | -45.3 | 76.3 | 19.2 | 16.4 | 4.4 | ||||||||||||||
Normalised EPS | -46.1 | 94.0 | 12.2 | 9.8 | 6.7 | ||||||||||||||
Normalised FDEPS | -46.1 | 94.0 | 12.2 | 9.8 | 6.7 | ||||||||||||||
Source: Company data, Verdhana estimates | |||||||||||||||||||
Cashflow statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY23 | FY24 | FY25F | FY26F | FY27F | ||||||||||||||
EBITDA | 1,954 | 3,445 | 4,106 | 4,778 | 4,990 | ||||||||||||||
Change in working capital | -139 | 55 | -109 | -60 | -14 | ||||||||||||||
Other operating cashflow | 266 | 292 | 125 | -131 | -3 | ||||||||||||||
Cashflow from operations | 2,081 | 3,792 | 4,123 | 4,587 | 4,972 | ||||||||||||||
Capital expenditure | -802 | -522 | -1,163 | -1,107 | -1,281 | ||||||||||||||
Free cashflow | 1,279 | 3,269 | 2,960 | 3,479 | 3,691 | ||||||||||||||
Reduction in investments | -343 | 213 | -150 | -158 | -165 | ||||||||||||||
Net acquisitions | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Dec in other LT assets | -42 | 54 | 59 | 48 | 38 | ||||||||||||||
Inc in other LT liabilities | 49 | -29 | 0 | 0 | 0 | ||||||||||||||
Adjustments | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
CF after investing acts | 943 | 3,507 | 2,869 | 3,369 | 3,564 | ||||||||||||||
Cash dividends | -754 | -1,807 | -3,057 | -3,430 | -3,764 | ||||||||||||||
Equity issue | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Debt issue | -1,213 | -21 | -110 | -99 | -89 | ||||||||||||||
Convertible debt issue | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Others | 73 | -1,377 | 169 | 190 | 208 | ||||||||||||||
CF from financial acts | -1,894 | -3,204 | -2,998 | -3,338 | -3,646 | ||||||||||||||
Net cashflow | -951 | 302 | -129 | 31 | -81 | ||||||||||||||
Beginning cash | 1,958 | 1,007 | 1,309 | 1,180 | 1,211 | ||||||||||||||
Ending cash | 1,007 | 1,309 | 1,180 | 1,211 | 1,130 | ||||||||||||||
Ending net debt | 114,304 | -209 | -190 | -320 | -328 | ||||||||||||||
Balance sheet (IDRbn) | |||||||||||||||||||
As at 31 Dec | FY23 | FY24 | FY25F | FY26F | FY27F | ||||||||||||||
Cash & equivalents | 1,007 | 1,309 | 1,180 | 1,211 | 1,130 | ||||||||||||||
Marketable securities | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Accounts receivable | 108 | 291 | 322 | 344 | 348 | ||||||||||||||
Inventories | 1,020 | 1,035 | 1,154 | 1,206 | 1,209 | ||||||||||||||
Other current assets | 311 | 612 | 619 | 627 | 636 | ||||||||||||||
Total current assets | 2,446 | 3,247 | 3,276 | 3,389 | 3,323 | ||||||||||||||
LT investments | 3,289 | 3,077 | 3,227 | 3,385 | 3,550 | ||||||||||||||
Fixed assets | 7,483 | 7,388 | 7,820 | 8,122 | 8,515 | ||||||||||||||
Goodwill | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other intangible assets | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other LT assets | 650 | 595 | 536 | 488 | 450 | ||||||||||||||
Total assets | 13,867 | 14,307 | 14,859 | 15,384 | 15,838 | ||||||||||||||
Short-term debt | 920 | 770 | 693 | 624 | 561 | ||||||||||||||
Accounts payable | 568 | 669 | 718 | 740 | 741 | ||||||||||||||
Other current liabilities | 470 | 924 | 924 | 924 | 924 | ||||||||||||||
Total current liabilities | 1,959 | 2,362 | 2,335 | 2,287 | 2,226 | ||||||||||||||
Long-term debt | 201 | 330 | 297 | 267 | 241 | ||||||||||||||
Convertible debt | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other LT liabilities | 368 | 339 | 339 | 339 | 339 | ||||||||||||||
Total liabilities | 2,528 | 3,031 | 2,970 | 2,893 | 2,805 | ||||||||||||||
Minority interest | 446 | 469 | 637 | 828 | 1,035 | ||||||||||||||
Preferred stock | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Common stock | 5,321 | 5,321 | 5,321 | 5,321 | 5,321 | ||||||||||||||
Retained earnings | 6,149 | 5,954 | 6,397 | 6,809 | 7,144 | ||||||||||||||
Proposed dividends | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other equity and reserves | -576 | -467 | -467 | -467 | -467 | ||||||||||||||
Total shareholders' equity | 10,894 | 10,808 | 11,251 | 11,663 | 11,998 | ||||||||||||||
Total equity & liabilities | 13,867 | 14,307 | 14,859 | 15,384 | 15,838 | ||||||||||||||
Liquidity (x) | |||||||||||||||||||
Current ratio | 1.25 | 1.37 | 1.40 | 1.48 | 1.49 | ||||||||||||||
Interest cover | 17.9 | 246.5 | 758.5 | – | – | ||||||||||||||
Leverage | |||||||||||||||||||
Net debt/EBITDA (x) | 58.50 | net cash | net cash | net cash | net cash | ||||||||||||||
Net debt/equity (%) | 1,049.2 | net cash | net cash | net cash | net cash | ||||||||||||||
Per share | |||||||||||||||||||
Reported EPS (IDR) | 81.02 | 157.19 | 176.33 | 193.52 | 206.50 | ||||||||||||||
Norm EPS (IDR) | 81.02 | 157.19 | 176.33 | 193.52 | 206.50 | ||||||||||||||
FD norm EPS (IDR) | 81.02 | 157.19 | 176.33 | 193.52 | 206.50 | ||||||||||||||
BVPS (IDR) | 548.81 | 544.48 | 566.79 | 587.54 | 604.43 | ||||||||||||||
DPS (IDR) | 91.01 | 154.02 | 172.77 | 189.62 | 202.34 | ||||||||||||||
Activity (days) | |||||||||||||||||||
Days receivable | 7.8 | 7.5 | 10.2 | 10.2 | 10.4 | ||||||||||||||
Days inventory | 63.2 | 63.2 | 60.2 | 62.1 | 63.4 | ||||||||||||||
Days payable | 36.9 | 38.1 | 38.1 | 38.4 | 38.9 | ||||||||||||||
Cash cycle | 34.0 | 32.7 | 32.2 | 33.9 | 35.0 | ||||||||||||||
Source: Company data, Verdhana estimates | |||||||||||||||||||
| Company | Bloomberg | M Cap | Rating | Target Price | Last Price | Upside | P/E (x) | P/B (x) | ROE (%) | Dividend Yield (%) | ||||
| Ticker | US$ mn | LC | 13-Oct | (%) | FY25F | FY26F | FY25F | FY26F | FY25F | FY26F | FY25F | FY26F | ||
| Malaysia | ||||||||||||||
| SD Guthrie | SDG MK | 8,655 | Buy | 5.80 | 5.29 | 10% | 15.1 | 13.9 | 1.7 | 1.6 | 11.3 | 11.7 | 3.8 | 3.8 |
| IOI Corporation | IOI MK | 5,797 | Buy | 4.50 | 3.95 | 14% | 16.5 | 16.5 | 2.0 | 1.9 | 12.2 | 11.8 | 3.3 | 3.5 |
| Kuala Lumpur Kepong | KLK MK | 5,380 | Buy | 23.00 | 20.42 | 13% | 22.0 | 15.5 | 1.6 | 1.5 | 7.3 | 10.0 | 3.4 | 3.9 |
| Genting Plantations | GENP MK | 1,042 | Not Rated | na | 4.91 | na | 13.1 | 13.0 | 0.8 | 0.8 | 6.6 | 6.4 | 5.2 | 4.6 |
| United Plantations | UPL MK | 3,444 | Not Rated | na | 23.40 | na | 18.4 | 18.3 | 5.2 | 5.0 | 28.3 | 27.3 | na | na |
| Johor Plantations Group | JPG MK | 863 | Not Rated | na | 1.46 | na | 12.9 | 12.7 | 1.2 | 1.2 | 9.6 | 9.2 | 4.0 | 3.9 |
| Sarawak Oil Palms | SOP MK | 718 | Not Rated | na | 3.39 | na | 7.0 | 7.1 | 0.7 | 0.7 | 11.1 | 10.4 | 3.7 | 3.2 |
| Average | 15.0 | 13.8 | 1.9 | 1.8 | 12.3 | 12.4 | 3.9 | 3.8 | ||||||
| Singapore | ||||||||||||||
| Wilmar International | WIL SP | 13,907 | Neutral | 3.20 | 2.89 | 11% | 9.3 | 8.6 | 0.7 | 0.6 | 7.5 | 13.1 | 7.2 | 7.6 |
| Golden Agri-Resources | GGR SP | 2,884 | Not Rated | na | 0.30 | na | na | na | na | na | na | na | na | na |
| First Resources | FR SP | 2,042 | Not Rated | na | 1.71 | na | 7.6 | 7.8 | 1.3 | 1.2 | 19.1 | 17.3 | 6.0 | 5.5 |
| Average | 8.4 | 8.2 | 1.0 | 0.9 | 13.3 | 15.2 | 6.6 | 6.6 | ||||||
| Indonesia | ||||||||||||||
| Triputra Agro Persada | TAPG IJ | 2,239 | Buy | 2,300 | 1,865 | 23% | 10.9 | 9.9 | 3.4 | 3.3 | 31.7 | 33.5 | 9.0 | 9.9 |
| Dharma Satya Nusantara | DSNG IJ | 1,106 | Not Rated | na | 1,730 | na | 9.2 | 9.2 | 1.5 | 1.3 | 17.2 | 15.0 | 2.1 | 3.1 |
| London Sumatera | LSIP IJ | 553 | Not Rated | na | 1,350 | na | 6.4 | 8.3 | 0.7 | 0.6 | 10.0 | 8.2 | 5.6 | 6.1 |
| Astra Agro Lestari | AALI IJ | 908 | Not Rated | na | 7,825 | na | 11.7 | 11.9 | 0.6 | 0.6 | 5.4 | 5.2 | 3.3 | 4.1 |
| Average | 9.7 | 9.8 | 1.6 | 1.5 | 15.6 | 15.4 | 4.9 | 5.8 | ||||||
| IDR tn | 2021 | 2022 | 2023 | 2024 | 2025F (B40) | 2026F (B45) | 2027F (B50) |
| Beginning Balance | 9.6 | 25.7 | 25.1 | 37.6 | 35.4 | 42.8 | 35.2 |
| Revenue | 72.5 | 35.7 | 34.6 | 28.4 | 60.1 | 58.0 | 72.6 |
| Biodiesel Expenditure | (52.0) | (34.7) | (18.3) | (29.4) | (50.4) | (63.3) | (72.4) |
| Other Expenditures | (1.5) | (1.6) | (2.6) | (2.3) | (2.3) | (2.3) | (2.3) |
| Surplus | 19.0 | (0.6) | 13.7 | (3.3) | 7.4 | (7.6) | (2.1) |
| Adjustment | (2.9) | - | (1.2) | 1.1 | - | - | - |
| Ending Balance | 25.7 | 25.1 | 37.6 | 35.4 | 42.8 | 35.2 | 33.1 |
| Assumption | |||||||
| Biodiesel consumption growth (%) | 3.0 | 3.0 | 3.0 | ||||
| Subsidy spread (IDR) | 6,000 | 6,500 | 6,800 | ||||
| CPO price (USD/ton) | 1,300 | 1,400 | 1,450 | ||||
| USD/IDR | 16,500 | 16,500 | 16,500 | ||||
| Levy rate (%) | 10.0 | 10.0 | 12.5 | ||||
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
| Rating Remains | Buy |
| Target price Increased from IDR 2,100 | IDR 2,300 |
| Closing price 13 October 2025 | IDR 1,855 |
| Implied upside | +24.0% |
| Market Cap (USD mn) | 2,224.5 |
| ADT (USD mn) | 2.2 |
M cap (USDmn) | 2,224.5 |
Free float (%) | 20.0 |
3-mth ADT (USDmn) | 2.2 |
(%) | 1M | 3M | 12M |
Absolute (IDR) | 22.0 | 62.0 | 108.4 |
Absolute (USD) | 20.7 | 58.6 | 96.1 |
Rel to Jakarta Stock Exchange Composite Index | 16.9 | 44.8 | 98.6 |
Sandy Ham (sandy.ham@verdhana.id)
Samuel Christian (samuel.christian@verdhana.id)
saya
In our recent report, we mentioned that one of the main catalysts for MEDC is AMMN IJ (Not rated)s operational
Brent Crude futures are back to USD81/bbl, recovering from a 13% decline in July.
MDKA recorded 2Q24 earnings of USD3mn, below our/consensus estimates.
Largely in line with our view (see Indonesia Nickel: Nickel ore drives downstream prices, 16 August 2024),
BBCA just released its bank-only Apr-25 results. Overall, we think...
As highlighted in our 23 March note (Repositioning, revamping, and reallocating)...